Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
The global Budesonide market was valued at US$ 8073 million in 2020 and is expected to reach US$ 9909.5 million by the end of 2029, growing at a CAGR of 3.2% during 2021-2029.
This report focuses on Budesonide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Budesonide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Budesonide Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
1 Budesonide Market Overview
1.1 Product Overview and Scope of Budesonide
1.2 Budesonide Segment by Type
1.2.1 Global Budesonide Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Budesonide Segment by Application
1.3.1 Global Budesonide Sales Comparison by Application: (2021-2029)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Global Budesonide Market Size Estimates and Forecasts
1.4.1 Global Budesonide Revenue 2016-2029
1.4.2 Global Budesonide Sales 2016-2029
1.4.3 Budesonide Market Size by Region: 2016 Versus 2021 Versus 2029
2 Budesonide Market Competition by Manufacturers
2.1 Global Budesonide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Budesonide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Budesonide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Budesonide Manufacturing Sites, Area Served, Product Type
2.5 Budesonide Market Competitive Situation and Trends
2.5.1 Budesonide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Budesonide Players Market Share by Revenue
2.5.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Budesonide Retrospective Market Scenario by Region
3.1 Global Budesonide Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Budesonide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Budesonide Market Facts & Figures by Country
3.3.1 North America Budesonide Sales by Country
3.3.2 North America Budesonide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Budesonide Market Facts & Figures by Country
3.4.1 Europe Budesonide Sales by Country
3.4.2 Europe Budesonide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Budesonide Market Facts & Figures by Region
3.5.1 Asia Pacific Budesonide Sales by Region
3.5.2 Asia Pacific Budesonide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Budesonide Market Facts & Figures by Country
3.6.1 Latin America Budesonide Sales by Country
3.6.2 Latin America Budesonide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Budesonide Market Facts & Figures by Country
3.7.1 Middle East and Africa Budesonide Sales by Country
3.7.2 Middle East and Africa Budesonide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Budesonide Historic Market Analysis by Type
4.1 Global Budesonide Sales Market Share by Type (2016-2021)
4.2 Global Budesonide Revenue Market Share by Type (2016-2021)
4.3 Global Budesonide Price by Type (2016-2021)
5 Global Budesonide Historic Market Analysis by Application
5.1 Global Budesonide Sales Market Share by Application (2016-2021)
5.2 Global Budesonide Revenue Market Share by Application (2016-2021)
5.3 Global Budesonide Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mylan Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Corporation Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Corporation Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Salix Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.6.1 Chiesi Farmaceutici Corporation Information
6.6.2 Chiesi Farmaceutici Description and Business Overview
6.6.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chiesi Farmaceutici Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Corporation Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Orion Corporation Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Cipla Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Corporation Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Synmosa Biopharma Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Corporation Information
6.11.2 Lunan Better Pharma Budesonide Description and Business Overview
6.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Lunan Better Pharma Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Corporation Information
6.12.2 Shanghai Sine Promod Budesonide Description and Business Overview
6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Shanghai Sine Promod Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Budesonide Manufacturing Cost Analysis
7.1 Budesonide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Budesonide
7.4 Budesonide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Budesonide Distributors List
8.3 Budesonide Customers
9 Budesonide Market Dynamics
9.1 Budesonide Industry Trends
9.2 Budesonide Growth Drivers
9.3 Budesonide Market Challenges
9.4 Budesonide Market Restraints
10 Global Market Forecast
10.1 Budesonide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Budesonide by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Budesonide by Type (2022-2029)
10.2 Budesonide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Budesonide by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Budesonide by Application (2022-2029)
10.3 Budesonide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Budesonide by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Budesonide by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Budesonide Sales (M Units) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Budesonide Sales (M Units) Comparison by Application (2021-2029)
Table 3. Global Budesonide Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Budesonide Covered in This Study
Table 5. Global Budesonide Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Budesonide Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Budesonide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Budesonide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Budesonide Average Price (USD/K Units) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Budesonide Manufacturing Sites and Area Served
Table 11. Manufacturers Budesonide Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Budesonide Sales by Region (2016-2021) & (M Units)
Table 16. Global Budesonide Sales Market Share by Region (2016-2021)
Table 17. Global Budesonide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Budesonide Sales by Country (2016-2021) & (M Units)
Table 19. North America Budesonide Sales Market Share by Country (2016-2021)
Table 20. North America Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Budesonide Revenue Market Share by Country (2016-2021)
Table 22. Europe Budesonide Sales by Country (2016-2021) & (M Units)
Table 23. Europe Budesonide Sales Market Share by Country (2016-2021)
Table 24. Europe Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Budesonide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Budesonide Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Budesonide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Budesonide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Budesonide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Budesonide Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Budesonide Sales Market Share by Country (2016-2021)
Table 32. Latin America Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Budesonide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Budesonide Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Budesonide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Budesonide Revenue Market Share by Country (2016-2021)
Table 38. Global Budesonide Sales (M Units) by Type (2016-2021)
Table 39. Global Budesonide Sales Market Share by Type (2016-2021)
Table 40. Global Budesonide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Budesonide Revenue Share by Type (2016-2021)
Table 42. Global Budesonide Price (USD/K Units) by Type (2016-2021)
Table 43. Global Budesonide Sales (M Units) by Application (2016-2021)
Table 44. Global Budesonide Sales Market Share by Application (2016-2021)
Table 45. Global Budesonide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Budesonide Revenue Share by Application (2016-2021)
Table 47. Global Budesonide Price (USD/K Units) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 51. AstraZeneca Budesonide Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 56. Teva Budesonide Product
Table 57. Teva Recent Developments/Updates
Table 58. Mylan Corporation Information
Table 59. Mylan Description and Business Overview
Table 60. Mylan Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 61. Mylan Budesonide Product
Table 62. Mylan Recent Developments/Updates
Table 63. Sandoz Corporation Information
Table 64. Sandoz Description and Business Overview
Table 65. Sandoz Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 66. Sandoz Budesonide Product
Table 67. Sandoz Recent Developments/Updates
Table 68. Cosmo Pharmaceuticals Corporation Information
Table 69. Cosmo Pharmaceuticals Description and Business Overview
Table 70. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 71. Cosmo Pharmaceuticals Budesonide Product
Table 72. Cosmo Pharmaceuticals Recent Developments/Updates
Table 73. Salix Corporation Information
Table 74. Salix Description and Business Overview
Table 75. Salix Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 76. Salix Budesonide Product
Table 77. Salix Recent Developments/Updates
Table 78. Chiesi Farmaceutici Corporation Information
Table 79. Chiesi Farmaceutici Description and Business Overview
Table 80. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 81. Chiesi Farmaceutici Budesonide Product
Table 82. Chiesi Farmaceutici Recent Developments/Updates
Table 83. Orion Corporation Corporation Information
Table 84. Orion Corporation Description and Business Overview
Table 85. Orion Corporation Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 86. Orion Corporation Budesonide Product
Table 87. Orion Corporation Recent Developments/Updates
Table 88. Cipla Corporation Information
Table 89. Cipla Description and Business Overview
Table 90. Cipla Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 91. Cipla Budesonide Product
Table 92. Cipla Recent Developments/Updates
Table 93. Synmosa Biopharma Corporation Information
Table 94. Synmosa Biopharma Description and Business Overview
Table 95. Synmosa Biopharma Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 96. Synmosa Biopharma Budesonide Product
Table 97. Synmosa Biopharma Recent Developments/Updates
Table 98. Lunan Better Pharma Corporation Information
Table 99. Lunan Better Pharma Description and Business Overview
Table 100. Lunan Better Pharma Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 101. Lunan Better Pharma Budesonide Product
Table 102. Lunan Better Pharma Recent Developments/Updates
Table 103. Shanghai Sine Promod Corporation Information
Table 104. Shanghai Sine Promod Description and Business Overview
Table 105. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (Million US$), Price (USD/K Units) and Gross Margin (2016-2021)
Table 106. Shanghai Sine Promod Budesonide Product
Table 107. Shanghai Sine Promod Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Budesonide Distributors List
Table 111. Budesonide Customers List
Table 112. Budesonide Market Trends
Table 113. Budesonide Growth Drivers
Table 114. Budesonide Market Challenges
Table 115. Budesonide Market Restraints
Table 116. Global Budesonide Sales Forecast by Type (2022-2029) & (M Units)
Table 117. Global Budesonide Sales Market Share Forecast by Type (2022-2029)
Table 118. Global Budesonide Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 119. Global Budesonide Revenue Market Share Forecast by Type (2022-2029)
Table 120. Global Budesonide Sales Forecast by Application (2022-2029) & (M Units)
Table 121. Global Budesonide Sales Market Share Forecast by Application (2022-2029)
Table 122. Global Budesonide Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 123. Global Budesonide Revenue Market Share Forecast by Application (2022-2029)
Table 124. Global Budesonide Sales Forecast by Region (2022-2029) & (M Units)
Table 125. Global Budesonide Sales Market Share Forecast by Region (2022-2029)
Table 126. Global Budesonide Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 127. Global Budesonide Revenue Market Share Forecast by Region (2022-2029)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Budesonide
Figure 2. Global Budesonide Market Share by Type in 2020 & 2029
Figure 3. Injectable Suspension Product Picture
Figure 4. Aerosols Product Picture
Figure 5. Inhalation Powder Product Picture
Figure 6. Tablet and Capsule Product Picture
Figure 7. Global Budesonide Market Share by Application in 2020 & 2029
Figure 8. Respiratory Disease Treatment
Figure 9. Nose Disease Treatment
Figure 10. Inflammatory Bowel Disease Treatment
Figure 11. Others
Figure 12. Global Budesonide Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 13. Global Budesonide Market Size 2016-2029 (US$ Million)
Figure 14. Global Budesonide Sales 2016-2029 (M Units)
Figure 15. Global Budesonide Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 16. Budesonide Sales Share by Manufacturers in 2020
Figure 17. Global Budesonide Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Budesonide Players: Market Share by Revenue in 2020
Figure 19. Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Budesonide Sales Market Share by Region (2016-2021)
Figure 21. Global Budesonide Sales Market Share by Region in 2020
Figure 22. Global Budesonide Revenue Market Share by Region (2016-2021)
Figure 23. Global Budesonide Revenue Market Share by Region in 2020
Figure 24. U.S. Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Budesonide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Budesonide by Type (2016-2021)
Figure 49. Sales Market Share of Budesonide by Application (2016-2021)
Figure 50. Sales Market Share of Budesonide by Application in 2020
Figure 51. Revenue Share of Budesonide by Application (2016-2021)
Figure 52. Revenue Share of Budesonide by Application in 2020
Figure 53. Manufacturing Cost Structure of Budesonide
Figure 54. Manufacturing Process Analysis of Budesonide
Figure 55. Budesonide Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
